ScinoPharm Taiwan Ltd (1789) — Capital Reinvestment Ratio
ScinoPharm Taiwan Ltd (1789) has a Capital Reinvestment Ratio of 0.24x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$343.96 Million) in capital expenditures (NT$82.01 Million). See ScinoPharm Taiwan Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ScinoPharm Taiwan Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks ScinoPharm Taiwan Ltd's Capital Reinvestment Ratio across 19 annual periods. Check 1789 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for ScinoPharm Taiwan Ltd from 2007 to 2025. For live market cap and broader valuation context, see market value of ScinoPharm Taiwan Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | NT$597.11 Million | NT$291.29 Million | ▲ +26.9% |
| 2024 | 0.38x | NT$750.91 Million | NT$288.73 Million | ▼ -68.8% |
| 2023 | 1.23x | NT$231.13 Million | NT$284.71 Million | ▲ +281.2% |
| 2022 | 0.32x | NT$773.79 Million | NT$250.04 Million | ▼ -48.7% |
| 2021 | 0.63x | NT$509.82 Million | NT$321.32 Million | ▲ +225.7% |
| 2020 | 0.19x | NT$946.31 Million | NT$183.10 Million | ▲ +44.4% |
| 2019 | 0.13x | NT$788.95 Million | NT$105.70 Million | ▲ +29.9% |
| 2018 | 0.10x | NT$1.23 Billion | NT$127.05 Million | ▼ -75.6% |
| 2017 | 0.42x | NT$971.71 Million | NT$410.93 Million | ▲ +53.6% |
| 2016 | 0.28x | NT$1.67 Billion | NT$458.52 Million | ▼ -56.9% |
| 2015 | 0.64x | NT$1.04 Billion | NT$667.58 Million | ▼ -44.5% |
| 2014 | 1.15x | NT$888.29 Million | NT$1.02 Billion | ▼ -13.0% |
| 2013 | 1.32x | NT$939.47 Million | NT$1.24 Billion | ▲ +47.5% |
| 2012 | 0.90x | NT$981.55 Million | NT$881.19 Million | ▲ +43.4% |
| 2011 | 0.63x | NT$1.29 Billion | NT$810.14 Million | ▲ +141.4% |
| 2010 | 0.26x | NT$1.56 Billion | NT$405.62 Million | ▲ +75.9% |
| 2009 | 0.15x | NT$1.30 Billion | NT$191.28 Million | ▲ +43.4% |
| 2008 | 0.10x | NT$1.41 Billion | NT$144.62 Million | ▼ -37.3% |
| 2007 | 0.16x | NT$504.50 Million | NT$82.74 Million | — |